Navigation Links
Sigma Launches The New Ion Channel Solutions Brochure and Web Site
Date:10/30/2007

ST. LOUIS, Oct. 30 /PRNewswire-FirstCall/ -- Sigma, a division of Sigma-Aldrich(TM) (Nasdaq: SIAL), is pleased to provide researchers additional Cell Biology solutions through the new Ion Channel Solutions Brochure and Ion Channels Web site (http://www.sigma.com/ionchannelsolutions). In addition to the most comprehensive product line in this area, the new tools will provide a wealth of scientific information to assist in the elucidation of ion channel function.

The Sigma Ion Channel Solutions Brochure provides a scientific overview of both voltage-gated and ligand-gated channels. Over 700 products are highlighted, including antibodies, toxins, inhibitors, and activators for ion channels, MISSION(R) RNAi libraries, and molecular biology products. Sigma's LOPAC bioactive compound libraries for ion channel drug discovery are also a feature.

The new Ion Channel Web site provides a portal to additional products and product information. The web site allows customers to access interactive tools, such as the online version of the Handbook of Receptor Classification and Signal Transduction, PathFinder Interactive Pathways, Your Favorite Gene(TM) search tool, and Sigma's own downloadable pathway slides.

"We believe that the Ion Channel Solutions Brochure and Web site are invaluable tools for scientists engaged in ion channel and drug discovery research. They offer a comprehensive line of products and information which, together, provide complete solutions to researchers in this area," said Tim Fleming, Director of Global Commercial Marketing at Sigma-Aldrich. "Sigma is committed to serving the needs of the cellular biology research community with best-in-class products and technologies."

To request your copy of the Sigma Ion Channel Solutions brochure and explore our new ion channel Web site, please visit us online at http://www.sigma.com/ionchannelsolutions.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 7,800 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award- winning Web site at http://www.sigma-aldrich.com.

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Company's expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Company's operations and conditions in the markets the Company serves. The Company does not undertake any obligation to update these forward-looking statements.

MISSION is a registered trademark belonging to Sigma-Aldrich Co. and its affiliate Sigma-Aldrich Biotechnology LP.


'/>"/>
SOURCE Sigma-Aldrich Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global ... industries to improve patient outcomes and quality of life, will now be offering ... being attributed to new regulatory requirements for all new drug products, including the ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for any ... So which eye do you rinse first if a dangerous substance enters both eyes? It’s ... Wash with its unique dual eye piece. , “Whether its dirt and debris, or ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... 30, 2017 Trends, opportunities and forecast in ... by technology (fingerprint, AFIS, iris recognition, facial recognition, hand ... by end use industry (government and law enforcement, commercial ... banking, and others), and by region ( North ... Asia Pacific , and the Rest of ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
Breaking Biology News(10 mins):